Clinical Trial Update: Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis [NA]

View source ↗

Summary

A clinical trial update indicates ongoing recruitment for assessing the safety and efficacy of adipose-derived regenerative cells (ADRCs) to improve hand dysfun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Adipose-Derived Regenerative Cells (ADRCs) (adipose-derived regenerative cells)

Snippet

Sponsor: Cytori Therapeutics | Conditions: Systemic Sclerosis (SSc), Hand Dysfunction | NA | Status: RECRUITING